By Indulal PM
MUMBAI (Reuters) - The BSE Sensex rose on Monday after two days of losses as software services exporters gained after Wipro posted solid earnings and joined domestic rivals in giving a positive outlook for the sector.
Value-buying also boosted recent underperformers, including lenders such as State Bank of India and more defensive stocks such as cigarette maker ITC
However, broader gains were capped as Reliance Industries
Investors are also growing hopeful the Reserve Bank of India will keep interest rates on hold at its policy review on January 28, which analysts say could spur additional gains in shares.
Also Read
"For the markets to sustain, we require a lot of good news from the RBI. The policy review is going to be the biggest trigger for the market in the short term," said Mehraboon Irani, head of private client group at Nirmal Bang Securities.
"All economy-related stocks will continue to disappoint, while defensive sectors like pharma and IT will continue to outperform the broader markets."
The Sensex closed up 0.67 percent at 21,205.05, while the broader Nifty ended higher 0.68 percent at 6,303.95.
Foreign institutional investors bought shares worth 753 million rupees on Friday, exchange data showed. FIIs have been buyers for seven consecutive sessions to the tune of 20.21 billion rupees.
Shares in Wipro gained 3.7 percent after the company said late on Friday it is eyeing more lucrative financial industry contracts from Europe and the United States to catch up with its bigger rivals and looks to grow its sales by up to 4 percent this quarter.
Tata Consultancy Services rose 5.7 percent on value-buying after falling 5.8 percent on Friday, the most in a day since October 2011 after its December quarter profit when adjusted for other income, as well as operating margin were seen lagging expectations, said traders.
Banking shares closed higher with State Bank of India gaining 1.3 percent ahead of the RBI policy review as investors expect the central bank to keep rates unchanged.
ITC
Shares in Aurobindo Pharma
Reliance MediaWorks'
However, Reliance Industries
(Reporting by Indulal PM; Editing by Subhranshu Sahu)


